Helen D. Clark, Anne Knisely, Alexandra Villanueva, Kathryn Lito, Miriam Bazan-Peregrino, Harris Owen, Robert Nutbrown, Helen Bridger, Matilde Saggese, David Apelian, Margaret Duffy, Amir A. Jazaeri. "A phase I, open-label, dose-finding, safety, tolerability, and exploratory trial of intraperitoneal THEO-260 in patients with high-grade serous or endometrioid ovarian cancer.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.tps5635